Unknown

Dataset Information

0

WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothers.


ABSTRACT:

Background

The Zimbabwean national prevention of mother-to-child HIV transmission (PMTCT) program provided primarily single-dose nevirapine (sdNVP) from 2002-2009 and is currently replacing sdNVP with more effective antiretroviral (ARV) regimens.

Methods

Published HIV and PMTCT models, with local trial and programmatic data, were used to simulate a cohort of HIV-infected, pregnant/breastfeeding women in Zimbabwe (mean age 24.0 years, mean CD4 451 cells/µL). We compared five PMTCT regimens at a fixed level of PMTCT medication uptake: 1) no antenatal ARVs (comparator); 2) sdNVP; 3) WHO 2010 guidelines using "Option A" (zidovudine during pregnancy/infant NVP during breastfeeding for women without advanced HIV disease; lifelong 3-drug antiretroviral therapy (ART) for women with advanced disease); 4) WHO "Option B" (ART during pregnancy/breastfeeding without advanced disease; lifelong ART with advanced disease); and 5) "Option B+:" lifelong ART for all pregnant/breastfeeding, HIV-infected women. Pediatric (4-6 week and 18-month infection risk, 2-year survival) and maternal (2- and 5-year survival, life expectancy from delivery) outcomes were projected.

Results

Eighteen-month pediatric infection risks ranged from 25.8% (no antenatal ARVs) to 10.9% (Options B/B+). Although maternal short-term outcomes (2- and 5-year survival) varied only slightly by regimen, maternal life expectancy was reduced after receipt of sdNVP (13.8 years) or Option B (13.9 years) compared to no antenatal ARVs (14.0 years), Option A (14.0 years), or Option B+ (14.5 years).

Conclusions

Replacement of sdNVP with currently recommended regimens for PMTCT (WHO Options A, B, or B+) is necessary to reduce infant HIV infection risk in Zimbabwe. The planned transition to Option A may also improve both pediatric and maternal outcomes.

SUBMITTER: Ciaranello AL 

PROVIDER: S-EPMC3107213 | biostudies-literature | 2011

REPOSITORIES: biostudies-literature

altmetric image

Publications

WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothers.

Ciaranello Andrea L AL   Perez Freddy F   Maruva Matthews M   Chu Jennifer J   Engelsmann Barbara B   Keatinge Jo J   Walensky Rochelle P RP   Mushavi Angela A   Mugwagwa Rumbidzai R   Dabis Francois F   Freedberg Kenneth A KA  

PloS one 20110602 6


<h4>Background</h4>The Zimbabwean national prevention of mother-to-child HIV transmission (PMTCT) program provided primarily single-dose nevirapine (sdNVP) from 2002-2009 and is currently replacing sdNVP with more effective antiretroviral (ARV) regimens.<h4>Methods</h4>Published HIV and PMTCT models, with local trial and programmatic data, were used to simulate a cohort of HIV-infected, pregnant/breastfeeding women in Zimbabwe (mean age 24.0 years, mean CD4 451 cells/µL). We compared five PMTCT  ...[more]

Similar Datasets

| S-EPMC3540037 | biostudies-literature
| S-EPMC527692 | biostudies-other
| S-EPMC7239451 | biostudies-literature
| S-EPMC8372940 | biostudies-literature
| S-EPMC5665493 | biostudies-literature
| S-EPMC7948351 | biostudies-literature
| S-EPMC4604210 | biostudies-literature
| S-EPMC5432093 | biostudies-literature
| S-EPMC4164178 | biostudies-literature
| S-EPMC3149453 | biostudies-literature